Schedule Common research planning uses once-daily subcutaneous injection
[unverified no linkable source] Vendor-assigned expiry and temperature-stability handling conventions for lyophilised peptides
confirm exact ratio per batch) Purity : High purity (9899% HPLC per component batch-specific COA available) Form : Lyophilized powder (co-lyophilized) Intended Use : For research purposes only Chemical Compounds in the Blend BPC-157 Chemical Name : Body Protection Compound-157 Sequence : Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Molecular Formula : CHNO Molecular Weight : ~1,794 Da Classification : Synthetic pentadecapeptide TB-500 (Thymosin Beta-4 fragment) Chemical Name : Thymosin Beta-4 active fragment Sequence : Ac-Lys-Lys-Thr-Glu-Thr-Gln (typical heptapeptide fragment) Molecular Formula : Varies by fragment (commonly referenced from Thymosin Beta-4) Molecular Weight : ~890 Da (for common fragment) Classification : Actin-sequestering peptide / regenerative fragment Research Background The BPC-157 + TB-500 blend is explored for complementary mechanisms: BPC-157 for localized tissue protection and healing, and TB-500 for systemic cytoskeletal organization, cell migration, and angiogenesis
They are also sometimes referred to as sleepwalking , although they are different from sleepwalking in a few key ways
I think it was just my own Dave Tilley: Googling
If your vial is 10 mg/mL and you need 2.5 mg, the math looks like this: 2.5 divided by 10 equals 0.25, multiplied by 100 equals 25 units
